Diagnostic Value of PUMA E-Tool in Prospective Case Finding of COPD in Primary Care: A Real-World Implementation Analysis

Main Article Content

Gustavo Zabert
Ignacio Zabert
https://orcid.org/0000-0002-8693-5901
Fabián Mariluán
https://orcid.org/0000-0002-2662-9523
Alfredo Morán
Damián Silva
https://orcid.org/0000-0002-2080-5127
Diego Goffredo
https://orcid.org/0000-0003-2333-4954
Walter Mattarucco
https://orcid.org/0000-0002-4861-0655
Pedro Grabre
Daniel Carles
Miguel Angel Bergna
https://orcid.org/0000-0001-5034-0749
Francisco Rovira
https://orcid.org/0000-0002-8279-3547

Abstract

Background COPD is a major cause of morbidity and mortality worldwide. Underdiagnosis is frequently reported since spirometry is not widely available in primary care settings. Therefore, a simple and accessible questionnaire-based strategy to select individuals for mandatory spirometry is desirable.


Methods: A cross-sectional study was performed to determine COPD prevalence among high-risk patients in five primary care facilities in Argentina and to assess the utility of PUMA score embedded in an electronic tool. Sample size was estimated between 683 to 893 cases for a prevalence of 20- 30% (with a CI of 95%), respectively.


Results: Over a 3-month period, a total of 866 patients were surveyed, with 836 meeting the inclusion criteria. The PUMA score was ≥ 5 in 503 patients and 440 patients underwent spirometry. Sixty-three patients were excluded (52 did not attend spirometry, 8 refused to participate and 3 for safety reasons). Spirometry diagnosed 120 cases of COPD, representing a COPD prevalence of 27.3% in the study population and 23.5% in the subgroup of patients with a PUMA score ≥ 5.


Conclusion: The PUMA score embedded in an electronic tool performed appropriately to select cases to diagnose COPD by spirometry in a primary care setting.

Article Details

Section

Artículos Originales

How to Cite

Diagnostic Value of PUMA E-Tool in Prospective Case Finding of COPD in Primary Care: A Real-World Implementation Analysis. (2025). Respirar, 17(2), 149-159. https://doi.org/10.55720/respirar.17.2.6

References

Mannino DM, Kiri VA. Changing the burden of COPD mortality. Int J COPD 2006;1(3):219-233. Doi:10.2147/copd.2006.1.3.219

Izquierdo JL, Barcina C, Jiménez J, Muñoz M, Leal M. Study of the burden on patients with chronic obstructive pulmonary disease. Int J Clin Pract 2009;63(1):87-97. Doi:10.1111/j.1742-1241.2008.01936.x

WHO. Chronic obstructive pulmonary disease (COPD). Burden of COPD. [Internet]. [Consultado 10 nov 2024]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)

Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28(3):523-532. Doi:10.1183/09031936.06.00124605

Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD. 2010;7(5):375-82. Doi: 10.3109/15412555.2010.510160

Boers E, Barrett M, Su JG et al. Global Burden of Chronic Obstructive Pulmonary Disease Through 2050. JAMA Netw Open 2023;6(12):e2346598. Doi: 10.1001/jamanetworkopen.2023.46598

Ho T, Cusack RP, Chaudhary N, Satia I, Kurmi OP. Under-and over-diagnosis of COPD: A global perspective. Breathe 2019;15(1):24-35. Doi:10.1183/20734735.0346-2018

Schiavi E, Stirbulov R, Hernández Vecino R et al. COPD screening in primary care in four Latin American countries: Methodology of the PUMA study. Arch Bronconeumol 2014;50(11). Doi:10.1016/j.arbres.2014.03.006

Diab N, Gershon AS, Sin DD et al. Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2018;198(9):1130-1139. Doi:10.1164/rccm.201804-0621CI

Lamprecht B, Soriano JB, Studnicka M et al. Determinants of Underdiagnosis of COPD in National and International Surveys. Chest 2015;148(4):971-985. Doi:10.1378/chest.14-2535

Hangaard S, Helle T, Nielsen C, Hejlesen OK. Causes of misdiagnosis of chronic obstructive pulmonary disease: A systematic scoping review. Respir Med 2017;129:63-84. Doi:10.1016/j.rmed.2017.05.015

Halpin DMG, Criner GJ, Papi A et al. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2021;203(1):24-36. Doi:10.1164/rccm.202009-3533SO

Gochicoa-Rangel L, Torre-Bouscoulet L, Salles Rojas A et al. Functional Respiratory Evaluation in the COVID-19 Era: The Role of Pulmonary Function Test Laboratories. Rev Investig Clin 2020;1-6. Doi:10.24875/ric.20000250

Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting Exacerbation of Chronic Obstructive Pulmonary Disease in a Longitudinal Cohort. Am J Respir Crit Care Med 2008;177(4):396-401. Doi:10.1164/rccm.200708-1290OC

Jordan RE, Lam KBH, Cheng KK et al. Case finding for chronic obstructive pulmonary disease: A model for optimizing a targeted approach. Thorax 2010;65(6):492-498. Doi:10.1136/thx.2009.129395

López Varela MV, Montes de Oca M, Rey A, Casas A, Stirbulov R, Di Boscio V. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study. Respirology 2016;21:1227-1234. Doi:10.1111/resp.12834

Culver BH, Graham BL, Coates AL et al. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med 2017;196(11):1463-1472. Doi:10.1164/rccm.201710-1981ST

Calverley PMA, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D. Development of a population-based screening questionnaire for COPD. COPD 2005;2(2):225-232.

Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ. Scoring System and Clinical Application of COPD Diagnostic Questionnaires. Chest 2006;129(6):1531-1539. Doi:10.1378/chest.129.6.1531

Martinez FJ, Raczek AE, Seifer FD et al. Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS). COPD J Chronic Obstr Pulm Dis 2008;5(2):85-95. Doi:10.1080/15412550801940721

Yawn BP, Mapel DW, Mannino DM et al. Development of the lung function questionnaire (LFQ) to identify airflow obstruction. Int J COPD 2010;5(1):1-10.

Hanania NA, Mannino DM, Yawn BP et al. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med 2010;104(8):1160-1170. Doi:10.1016/j.rmed.2010.02.009

Spyratos D, Haidich AB, Chloros D, Michalopoulou D, Sichletidis L. Comparison of Three Screening Questionnaires for Chronic Obstructive Pulmonary Disease in the Primary Care. Respiration 2017;93(2):83-89. Doi:10.1159/000453586

Stanley AJ, Hasan I, Crockett AJ, van Schayck OCP, Zwar NA. Validation of the COPD diagnostic questionnaire in an Australian general practice cohort: A cross-sectional study. Prim Care Respir J 2014;23(1):92-97. Doi:10.4104/pcrj.2014.00015

Frith P, Crockett A, Beilby J et al. Simplified COPD screening: Validation of the PiKo-6® in primary care. Prim Care Respir J 2011;20(2):190-198. Doi:10.4104/pcrj.2011.00040

Franco-Marina F, Fernandez-Plata R, Torre-Bouscoulet L et al. Efficient screening for COPD using three steps: a cross-sectional study in Mexico City. NPJ Prim Care Respir Med 2014;24:14002. Doi: 10.1038/npjpcrm.2014.2.

Barnes T, Fromer L. Spirometry use: detection of chronic obstructive pulmonary disease in the primary care setting. Clin Interv Aging 2011;47. Doi:10.2147/CIA.S15164

Bergna MA, García GR, Alchapar R et al. Development of a simple binary response questionnaire to identify airflow obstruction in a smoking population in Argentina. Eur Respir Rev 2015;24(136):320-326. Doi: 10.1183/16000617.00005214

Lopez Varela MV, Montes De Oca M, Wehrmeister FC, Rodriguez C, Ramirez L, Menezes A. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population. Int J Chron Obstruct Pulmon Dis 2019; 14:1901-1911. Doi:10.2147/COPD.S206250

Aaron SD, Vandemheen KL, Whitmore GA et al. Early Diagnosis and Treatment of COPD and Asthma — A Randomized, Controlled Trial. N Eng J Med 2024;390(22):2061-2073. Doi:10.1056/nejmoa2401389.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)